Sort
10,766 grants matching “checkpoint inhibitor”
MITOTIC CHECKPOINT GENE MAD2 IN VERTEBRATES
$278,346Sloan-Kettering Institute For Cancer Res · R01 · FY2001 · GM
HTLV-I Tax activates the anaphase promoting complex
$278,242Chou-Zen Giam · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2012 · CA
HTLV-I Tax activates the anaphase promoting complex
$278,242Chou-Zen Giam · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2011 · CA
Islet Growth Factors Transgenic and Viral Modeling
$278,134Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · DK
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$277,899James R. Heath · California Institute Of Technology · U54 · FY2017 · CA
REGULATED PROTEOLYSIS AND LONG-TERM MEMORY
$277,875Wake Forest University Health Sciences · R01 · FY2001 · MH
Project 1: Targeting Metastatic Prostate Cancer Patients with Biallelic Loss of CDK12
$277,748Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2019 · CA
Regulation of human endogenous retroviruses in the context of cancer immunotherapy
$277,695Davide Gabellini · San Raffaele Hospital · R21 · FY2020 · CA
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells
$277,685Roni Shouval · Sloan-Kettering Inst Can Research · K08 · FY2023 · CA
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells
$277,685Roni Shouval · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA
A multimodal approach for precision immuno-oncology in lymphoma treated with CAR-T cells
$277,685Roni Shouval · Sloan-Kettering Inst Can Research · K08 · FY2025 · CA
Ribosome Biogenesis and p53 Dependent Cell Cycle Control
$277,449University Of Illinois At Chicago · R01 · FY2004 · CA
Ribosome Biogenesis and p53 Dependent Cell Cycle Control
$277,449University Of Illinois At Chicago · R01 · FY2002 · CA
Ribosome Biogenesis and p53 Dependent Cell Cycle Control
$277,449University Of Illinois At Chicago · R01 · FY2003 · CA
Mitotic Catastrophe in Tumor Cells
$277,449University Of Illinois At Chicago · R01 · FY2002 · CA
Ribosome Biogenesis and p53 Dependent Cell Cycle Control
$277,449University Of Illinois At Chicago · R01 · FY2005 · CA
DNA damage signaling in oxygen toxicity in lung cells
$277,326Kumuda C Das · Univ Of Arkansas For Med Scis · R01 · FY2006 · HL
Integrated proteogenomics to identify neopeptides presented by MHC Class I
$277,134Udayan Guha · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Project 3: Improving therapeutic approaches for breast cancer brain metastases
$277,115Jean Zhao · Dana-Farber Cancer Inst · P50 · FY2023 · CA
MITOTIC CHECKPOINT GENE MAD2 IN VERTEBRATES
$277,100Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · GM
MITOTIC CHECKPOINT GENE MAD2 IN VERTEBRATES
$277,100Sloan-Kettering Institute For Cancer Res · R01 · FY2002 · GM
MITOTIC CHECKPOINT GENE MAD2 IN VERTEBRATES
$277,100Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · GM
THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONG
$277,067Edward P Hasty · Buck Institute For Research On Aging · P01 · FY2008 · AG
Prevention of Prostate Cancer by Sulforaphane
$277,000Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
Prevention of Prostate Cancer by Sulforaphane
$276,968Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · CA